Affiliation:
1. Department of Clinical Sciences, Faculty of Veterinary Medicine Semnan University Semnan Iran
2. Department of Quality Control Razi Vaccine and Serum Research, Education and Extension Organization (AREEO) Karaj Iran
3. Department of Internal Medicine, Faculty of Veterinary Medicine University of Tehran Tehran Iran
Abstract
AbstractBackgroundIn goat kids, choosing the appropriate age to administer the first dose of goat pox disease (GTP) vaccine requires knowing when maternal antibody decline concentrations.ObjectiveDetermine the persistence of maternal antibodies against goat pox virus (GTPV) in goat kids.AnimalsTwenty Saanen goat kids from birth to 120 days old.MethodsIn 2 groups, including: control (receiving colostrum from nonvaccinated does) and treatment (receiving colostrum from vaccinated does). On zero, 3, 7, 14, 21, 28, 42, 56, 70, 100 and 120 days after the birth, virus neutralization test was used to measure the serum concentration of antibodies against GTPV.ResultsAt the age of 56 days, the first seronegative goat kids (n = 2) were recorded in the treatment group. At the age of 120 days, all the goat kids in the treatment group were seronegative. The average virus neutralization index (VNI) of the goat kids became negative at the age of 100 to 120 days. All goat kids in the control group were negative at all times.Conclusions and Clinical ImportanceOne hundred to 120 days of the age seems to be the time to administer the first GTP vaccine in the goat kids with passive immunity against goat pox.
Reference26 articles.
1. A review of sheep pox and goat pox: perspective of their control and eradication in Iran;Mirzaie K;J Adv Vet Anim Res,2015
2. A review on Sheeppox and Goatpox: insight of epidemiology, diagnosis, treatment and control measures in Ethiopia;Hurisa TT;J Infect Dis Epidemiol,2018
3. The Genomes of Sheeppox and Goatpox Viruses
4. Review of sheep and goat pox disease: current updates on epidemiology, diagnosis, prevention and control measures in Ethiopia;Zewdie G;Anim Dis,2021
5. Experimental evaluation of the cross‐protection between Sheeppox and bovine lumpy skin vaccines;Hamdi J;Sci Rep,2020